Human CD11a Monoclonal Antibody, Endotoxin 0.05 EU/mg

Artikelnummer: ABB-YR0112
Artikelname: Human CD11a Monoclonal Antibody, Endotoxin 0.05 EU/mg
Artikelnummer: ABB-YR0112
Hersteller Artikelnummer: YR0112
Alternativnummer: ABB-YR0112-5MG,ABB-YR0112-20MG
Hersteller: ABclonal
Kategorie: Antikörper
Applikation: ELISA, NeA
Immunogen: Human CD11a
Alternative Synonym: CD11A, LFA-1, LFA1A
Efalizumab is a monoclonal anti-CD11a antibody used to treat moderate to severe plaque psoriasis.Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin.Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes. As a result efalizumab decreases cell surface expression of CD11a.
NCBI: 3683
UniProt: P20701
Reinheit: >95% Determined by SDS-PAGE
Target-Kategorie: CD11a
Application Verdünnung: In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Anwendungsbeschreibung: Cross-Reactivity: <0.05EU/mg (<0.00005EU/µg) Determined by LAL gel clotting assay. ResearchArea: Cancer immunology